학술논문

Myocardial scarring and recurrence of ventricular arrhythmia in patients surviving an out‐of‐hospital cardiac arrest.
Document Type
Article
Source
Journal of Cardiovascular Electrophysiology. Nov2023, Vol. 34 Issue 11, p2286-2295. 10p.
Subject
*DIGITAL image processing
*MYOCARDIUM
*HUMAN research subjects
*ANALYSIS of variance
*CONFIDENCE intervals
*MAGNETIC resonance imaging
*RETROSPECTIVE studies
*MANN Whitney U Test
*FISHER exact test
*DISEASE relapse
*RISK assessment
*INFORMED consent (Medical law)
*DIAGNOSTIC imaging
*T-test (Statistics)
*CARDIAC arrest
*VENTRICULAR arrhythmia
*DESCRIPTIVE statistics
*SENSITIVITY & specificity (Statistics)
*RECEIVER operating characteristic curves
*DATA analysis software
*DISEASE risk factors
Language
ISSN
1045-3873
Abstract
Introduction: Prediction of recurrent ventricular arrhythmia (VA) in survivors of an out‐of‐hospital cardiac arrest (OHCA) is important, but currently difficult. Risk of recurrence may be related to presence of myocardial scarring assessed with late gadolinium enhancement cardiac magnetic resonance (LGE‐CMR). Our study aims to characterize myocardial scarring as defined by LGE‐CMR in survivors of a VA‐OHCA and investigate its potential role in the risk of new VA events. Methods: Between 2015 and 2022, a total of 230 VA‐OHCA patients without ST‐segment elevation myocardial infarction had CMR before implantable cardioverter‐defibrillator implantation for secondary prevention at Copenhagen University Hospital, Rigshospitalet, and Hospital Clínic, University of Barcelona, of which n = 170 patients had a conventional (no LGE protocol) CMR and n = 60 patients had LGE‐CMR (including LGE protocol). Scar tissue including core, border zone (BZ) and BZ channels were automatically detected by specialized investigational software in patients with LGE‐CMR. The primary endpoint was recurrent VA. Results: After exclusion, n = 52 VA‐OHCA patients with LGE‐CMR and a mean left ventricular ejection fraction of 49 ± 16% were included, of which 18 (32%) patients reached the primary endpoint of VA. Patients with recurrent VA in exhibited greater scar mass, core mass, BZ mass, and presence of BZ channels compared with patients without recurrent VA. The presence of BZ channels identified patients with recurrent VA with 67% sensitivity and 85% specificity (area under the ROC curve (AUC) 0.76; 95% CI: 0.63–0.89; p <.001) and was the strongest predictor of the primary endpoint. Conclusions: The presence of BZ channels was the strongest predictor of recurrent VA in patients with an out of‐hospital cardiac arrest and LGE‐CMR. [ABSTRACT FROM AUTHOR]